Turnaround

Gossamer Bio is navigating a significant challenge following disappointing late-stage trial results for its lead drug candidate, Seralutinib. The biopharmaceutical...

A significant earnings beat and promising clinical developments have prompted a wave of analyst upgrades for Q32 Bio, signaling a...

Despite posting a robust surge in profit for 2025, shares of CB Services have faced significant selling pressure this March....

The departure of ABO Wind AG's chief financial officer has introduced fresh uncertainty just as the renewable energy developer secured...

A critical pillar of BayWa's four-billion-euro debt reduction plan has collapsed, throwing the agricultural and energy group's financial rehabilitation into...

British engineering giant Rolls-Royce is accelerating a multi-faceted strategic transformation, painting a picture of formidable operational strength. This momentum is...

The cornerstone of Thyssenkrupp's corporate overhaul is under severe threat. The German industrial group's planned sale of its struggling steel...

Austria's OMV is undergoing a profound strategic shift. The company's rapidly expanding chemicals business is now compensating for weaknesses in...

Investors have delivered a harsh verdict on Evotec SE's latest strategic update. The Hamburg-based biotechnology services firm saw its equity...

Oracle is undergoing a fundamental strategic shift, channeling immense resources toward securing a dominant position in the artificial intelligence sector....